SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported) August 11, 2009
E. I. du Pont de Nemours and Company
(Exact Name of Registrant as Specified in Its Charter)
| |
|
|
|
|
Delaware
(State or Other Jurisdiction
Of Incorporation)
|
|
1-815
(Commission
File Number)
|
|
51-0014090
(I.R.S. Employer
Identification No.) |
1007 Market Street
Wilmington, Delaware 19898
(Address of principal executive offices)
Registrant’s telephone number, including area code: (302) 774-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
On August 11, 2009 the Board of Directors of E. I. du Pont de Nemours and Company (“Company”) took
the following actions:
| |
• |
|
Named Nicholas C. Fanandakis, age 53, Senior Vice President (“SVP”) effective September
1, 2009, at which time he will begin to transition into the role of Chief Financial
Officer. Effective November 1, 2009, he will become SVP and Chief Financial Officer. |
| |
| |
• |
|
Appointed Mr. Fanandakis to the Office of the Chief Executive effective September 1,
2009. |
The Board’s Compensation Committee also approved an increase in Mr. Fanandakis’ annual salary from
$387,708 to $500,000 effective September 1, 2009 to reflect his appointments. Consistent
therewith, Mr. Fanandakis’ target short-term incentive award for 2009 under the Company’s Equity
and Incentive Plan will increase from $328,500 to $464,100.
Mr. Fanandakis was named to his current position, Group Vice President- Applied BioSciences, in
January 2008. Prior to that, he was vice president and general manager- DuPont Chemical Solutions
Enterprise from September 2003 through September 2006 and vice president- Corporate Plans from
October 2006 through December 2007.
Jeffrey L. Keefer, EVP and Chief Financial Officer, will remain EVP and transition from the
position of Chief Financial Officer to assume leadership responsibility for the Company’s
Performance Coatings business, corporate strategy development,
Information Technology and overall cost and working
capital productivity efforts effective November 1, 2009.
Richard R. Goodmanson, EVP and Chief Operating Officer has elected to retire from the Company
effective September 30, 2009. As previously reported on Form 8-K filed with the Securities and
Exchange Commission on October 6, 2008, Mr. Goodmanson will remain with the Company as a consultant
for three years following his retirement.
Item 8.01 Other Events
On August 13, 2009, the Company issued a press release announcing a number of organizational
changes, including redefining its external financial reporting to aggregated segments. A copy of
the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
The
following exhibits are filed herewith:
| |
99.1 |
|
Press Release issued by the Company, dated August 13,
2009. |
2